Discover how cfDNA fragmentome tests could help detect liver disease early and track health. Learn more about this emerging ...
Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...
Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI - ...
AI Nose deployment into front-end wafer fabrication facilities marks a critical validation step in semiconductor manufacturing environmentsRecurring revenue visibility strengthens as AI Nose deploymen ...
The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...
Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...
Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...
Artificial intelligence is rapidly transforming health care. AI systems can now detect diabetic eye disease from retinal ...
Objective A panel of antibodies against three antigens, University Hasselt (UH)-rheumatoid arthritis (RA).305, 318 and 329, ...
PECOTA, which stands for Player Empirical Comparison and Optimization Test Algorithm, is BP’s proprietary system that projects player and team performance PECOTA is a system that takes a player’s past ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results